In addition, this mutation in ANO5 was confirmed to be absent in the control group, including five patients with FCOD, five patients with polyostotic fibrous dysplasia, and eight patients with juvenile ossifying fibromas. The gene discussed is ANO5; the disease is polyostotic fibrous dysplasia.